# Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

> **NCT04485026** · PHASE2 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Non Small Cell Lung Cancer
- Oligoprogressive

## Interventions

- **RADIATION:** Local consolidative radiation therapy
- **DRUG:** Standard of care radiation therapy

## Key facts

- **NCT ID:** NCT04485026
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-11-04
- **Primary completion:** 2024-05-09
- **Final completion:** 2024-05-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No enrollments, low patient population as well as a dramatic change in the insurance approval processes for oligoprogressive state with eviCore saying they do not support SBRT in this setting at all.
- **Last updated:** 2025-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04485026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04485026, "Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04485026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*